Cargando…
Anti-Colorectal Cancer Effects of Probiotic-Derived p8 Protein
Recently, we reported a novel therapeutic probiotic-derived protein, p8, which has anti-colorectal cancer (anti-CRC) properties. In vitro experiments using a CRC cell line (DLD-1), anti-proliferation activity (about 20%) did not improve after increasing the dose of recombinant-p8 (r-p8) to >10 μM...
Autores principales: | An, Byung Chull, Hong, Sunwoong, Park, Ho Jin, Kim, Bong-Kyu, Ahn, Jun Young, Ryu, Yongku, An, Jae Hyung, Chung, Myung Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723380/ https://www.ncbi.nlm.nih.gov/pubmed/31430963 http://dx.doi.org/10.3390/genes10080624 |
Ejemplares similares
-
Anti-Cancer Roles of Probiotic-Derived P8 Protein in Colorectal Cancer Cell Line DLD-1
por: An, Byung Chull, et al.
Publicado: (2023) -
Toxicological Evaluation of a Probiotic-Based Delivery System for P8 Protein as an Anti-Colorectal Cancer Drug
por: An, Byung Chull, et al.
Publicado: (2021) -
Colorectal Cancer Therapy Using a Pediococcus pentosaceus SL4 Drug Delivery System Secreting Lactic Acid Bacteria-Derived Protein p8
por: An, Byung Chull, et al.
Publicado: (2019) -
A synthetic probiotic engineered for colorectal cancer therapy modulates gut microbiota
por: Chung, Yusook, et al.
Publicado: (2021) -
Randomized, Double-blind, Placebo-controlled Study of a Multispecies Probiotic Mixture in Nonalcoholic Fatty Liver Disease
por: Ahn, Sang Bong, et al.
Publicado: (2019)